Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2010
11/24/2010CN101181424B Medicament for curing aberrat menses as well as preparation technique thereof
11/24/2010CN101181353B Traditional Chinese medicine preparation for curing prostate gland disease and preparation method thereof
11/24/2010CN101181327B Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof
11/24/2010CN101167730B Compound betamethasone suspension injection
11/24/2010CN101152189B Polyene phosphatidyl choline injection and method for preparing the same
11/24/2010CN101095725B Chinese traditional medicine for treating psoriasis
11/24/2010CN101062022B Colchicine patch absorbing from skin for treating acute goute arthritis and the preparing method thereof
11/24/2010CN101049297B High DNA type fatty ethyl ester in high purity, manufacturing method and preparation
11/24/2010CN101006124B Polymeric film
11/23/2010US7838699 Embolization using degradable crosslinked hydrogels
11/23/2010US7838592 Starch-based coating composition
11/23/2010US7838564 treatment of cutaneous T-cell lymphoma by topically applying composition of a Nitrogen Mustard or a HX salt of the Nitrogen Mustard to the affected skin, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol
11/23/2010US7838560 Urokinase inhibitors, production and use thereof
11/23/2010US7838558 adapalene in topical gels, creams or lotions in higher concentration for skin disorders such as acne
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010US7838208 forming multi-component patterns via defining regions of localized magnetic field maxima and minima on a substrate; lithographic applications; use in electronics, photonics, genome analysis, drug discovery, and cellular systems
11/23/2010US7838055 microcrystallization of xylitol and maltitol via spraying liquid feed thereof, evaporating solvent, conditioning, milling; for use in confectionery, foodstuffs, oral hygiene products and pharmaceuticals and dietetic
11/23/2010US7838043 administering scavenger of superoxide anion or nitric oxide comprising fine powder of platinum (colloid) which is prepared by metal salt reduction in presence of water-soluble polymer comprising polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, cyclodextrin, amylopectin, and methylcellulose
11/23/2010US7838037 of active ingredients for topical use; dissolving active ingredient in ethyl acetate with acrylate copolymer; double-layer and triple-layer microcapsules; oxidation resistance; storage stability
11/23/2010US7838036 beads with nucleic acids bound to surface; biochips; microfluidics, microelectromechanical systems
11/23/2010US7838035 Microsphere powder of high density, swellable, deformable, durable occlusion-forming microspheres
11/23/2010US7838034 Drug(s) partially undissolved in water-based suspending medium with specific particle size; dilution with phosphate buffer; dissolving; paracetamol injection
11/23/2010US7838033 Composition for rapid disintegrating tablet in oral cavity
11/23/2010US7838032 An expectorant drug delivery dosage forms comprises a sustained release portion and an immediate release portion; relieving from bronchial mucus accumulation
11/23/2010US7838031 Method of administering a partial dose using a segmented pharmaceutical tablet
11/23/2010US7838030 solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on S-adenosylmethionine, or salts thereof, in combination with inositol and/or derivatives thereof with the addition of magnesium oxide as stabilizer
11/23/2010US7838029 non-effervescent, solid dosage form containing mirtazapine, which is used to form mirtazapine pharmaceutical tablets; dosage form contains mirtazapine, a hydrophilic component, and at least one lubricant; may also contain a salivating agent
11/23/2010US7838028 Multilayer core; compression sintering
11/23/2010US7838027 Pantoprazole multiparticulate formulations
11/23/2010US7838026 Burst-release polymer composition and dosage forms comprising the same
11/23/2010US7838025 products such as wet wipes and absorbents capable of providing a skin health benefit when utilized in the intended fashion; products comprise an agent such as a botanical extract, which is capable of increasing the activity of sphingomyelinase and/or decreasing the activity of ceramidase
11/23/2010US7838024 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
11/23/2010US7838023 Ethanamine, 2-L[5-oxido-4-phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]-N,N-bis[2-[[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]ethyl]-; cardiovascular diseases; inhibiting platelet aggregation, platelet adhesion caused by the exposure of blood to a medical device; abnormal cell proliferation
11/23/2010US7838018 Quaternary hydrocarbon ammonium halogenide and monophosphoryl lipid; synergistic potentiation; kits; tuberculosis
11/23/2010US7838015 Adjuvanted meningococcus compositions
11/23/2010US7837708 Placing a length of suture into a sterile container;obtaining an autogenous blood component by centrifuging the patient's blood,dding an anticoagulant to keep the blood component in suspension and then adding to the container where the suture soaks up the autogenous blood component; surgery
11/23/2010US7837663 Odor absorber; color sensitive to odors; colorimetric analysis
11/23/2010US7837647 Medication delivery system and monitor
11/23/2010US7836883 Methods for treating rhinitis and conjunctivitis
11/23/2010CA2799515A1 Delayed release rasagiline formulation
11/23/2010CA2727899A1 Delayed release rasagiline formulation
11/23/2010CA2478094C Methods of inducing terminal differentiation
11/23/2010CA2464502C Granules or powder for the production of coating agents and binders for pharmaceutical forms
11/23/2010CA2457114C Device for the administration of an active agent to the human skin
11/23/2010CA2452717C Antimicrobial melamine resin and products made therefrom
11/23/2010CA2444529C Micellar drug delivery systems for hydrophobic drugs
11/23/2010CA2435414C Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
11/23/2010CA2434775C Compounds for use in the treatment of skin conditions
11/23/2010CA2433585C Pharmaceutical compositions containing donepezil hydrochloride
11/23/2010CA2385150C Vascular coating composition
11/23/2010CA2382133C Phospholipid-based powders for drug delivery
11/23/2010CA2373302C Conditioned cell culture medium compositions and methods of use
11/23/2010CA2367402C Stable pharmaceutical dosage form for paroxetine anhydrate
11/23/2010CA2354148C Aerosol formulations for buccal and pulmonary application
11/23/2010CA2332808C Compositions of ascorbic acid derivatives for treatment of skin diseases
11/23/2010CA2302700C New use for budesonide and formoterol
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/23/2010CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
11/19/2010CA2701484A1 Ondansetron film compositions
11/18/2010WO2010132882A2 Sublingual dexmedetomidine compositions and methods of use thereof
11/18/2010WO2010132857A1 Composition and method of preparation of polysaccharide gel-based artificial, biodegradable skin scaffolds
11/18/2010WO2010132827A1 Low-molecular dextran for powder inhalations
11/18/2010WO2010132819A1 Coated pharmaceutical capsule dosage form
11/18/2010WO2010132730A2 Hyaluronic acid (ha) injection vehicle
11/18/2010WO2010132664A1 Compositions and methods for drug delivery
11/18/2010WO2010132662A1 Powder formulations of potassium-binding active agents
11/18/2010WO2010132635A1 Burst drug release compositions
11/18/2010WO2010132605A1 Pharmaceutical system for trans-membrane delivery
11/18/2010WO2010132562A2 Transdermal delivery of metformin
11/18/2010WO2010132474A2 Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields
11/18/2010WO2010132471A2 Synthesis of stable elastomeric negative acoustic contrast particles
11/18/2010WO2010132331A2 Ingestible event markers comprising an ingestible component
11/18/2010WO2010132286A1 Orally administered tablet formulation of an antianxiolytic compound
11/18/2010WO2010132205A1 Film coatings containing fine particle size detackifiers and substrates coated therewith
11/18/2010WO2010132204A1 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
11/18/2010WO2010132095A1 Method and composition to improve absorption of therapeutic agents
11/18/2010WO2010132047A1 Guanosine/gmp gels and uses thereof
11/18/2010WO2010131909A2 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
11/18/2010WO2010131907A2 Sirna delivery system using self-assembled polymeric nanoparticles
11/18/2010WO2010131777A1 Fine particles of crystalline polyol and method of preparing same
11/18/2010WO2010131486A1 Intranasal pharmaceutical compositions with improved pharmacokinetics
11/18/2010WO2010131265A1 Novel pharmaceutical compositions of choline fenofibrate
11/18/2010WO2010131258A1 Clay nanocomposite forming microcapsule useful for guest encapsulation and process thereof
11/18/2010WO2010131208A1 Granular delivery system
11/18/2010WO2010131207A1 Method of preparing a granular delivery system
11/18/2010WO2010130982A2 Composition
11/18/2010WO2010130897A1 Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
11/18/2010WO2010130896A2 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130728A2 Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers
11/18/2010WO2010130462A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma
11/18/2010WO2010130435A1 Oil-in-water emulsion of mometasone
11/18/2010WO2010130428A1 Oil-in-water emulsion of mometasone and propylene glycol
11/18/2010WO2010130418A2 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
11/18/2010WO2010130396A2 Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
11/18/2010WO2010130393A2 Orodispersible tablet containing a vardenafil salt
11/18/2010WO2010130392A1 Desfesoterodine in the form of a tartaric acid salt
11/18/2010WO2010113176A3 Novel copolymers for controlled release delivery system
11/18/2010WO2010111650A3 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
11/18/2010WO2010111641A3 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
1 ... 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 ... 2991